Diabetic Neuropathy

Clinical Trial in the Connecticut Area

We are currently conducting a clinical study in the Connecticut area to assess whether an investigational study drug is safe and effective in treating or preventing the progression of nerve damage in patients with mild to moderate nerve damage caused by their diabetes (diabetic neuropathy). To qualify for this study, you must:

• Be between the ages of 18 and 75
• Been diagnosed with type 1 (insulin-dependent) or type 2 (non insulin-dependent) diabetes for at least 1 year
• Have had your glucose levels well controlled for at least 3 months
• Are experiencing some symptoms of diabetic neuropathy (e.g. loss of sensation, numbness, tingling, prickling, shooting pains, or unusual tenderness in the feet or legs)

In order to see if you qualify, please fill out our qualification form, and one of our study coordinators will contact you. If you qualify you will receive study medication(s) as well as all study-related assessments at no cost.

Compensation is available for time and travel.

Contact us if you are interested in more information.